HSPB1 and hepatocellular carcinoma: Meanwhile, m654-sEV effectively distributed miR-654-5p to HCC cells, targeting HSPB1 and increasing ferroptosis to reduce sorafenib resistance,167,169, 170, 171 miR-654-5p reduces HSPB1 protein levels and thereby increases sorafenib-induced ferroptosis.15